Among the days top 10 gainers in the A group Glaxosmithkline Pharmaceuticals gained 5.87% on 7 August 2007 as it closed at 1207.20 compared to previous close of 1140.25 on 6 August 2007. Gain in the stock prices of the company will benefit various mutual fund schemes, which have invested in the stocks of the company.
Magnum SFU- Pharma Fund (D) is likely to benefit the most as it has the highest percentage hold of the stocks of the company compared to its peer groups who have invested in the stocks of the company. Magnum SFU- Pharma Fund (D) has 11.26% share of its portfolio invested in the stocks of the company with 43704 units in July 2007.
Franklin India Taxshield 98 is also likely to benefit as scheme has invested 5.58% of its portfolio with 700 units in the stocks of the company in July 2007.
However, scheme like Principal Dividend Yield Fund (G) is likely to benefit to a limited extent as scheme sold 1.38% of portfolio nearly 12,039 units of the company and holds 36401 units as on July 2007 as compared to 48,440 units in June 2007.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment